or
Looking to list your PhD opportunities? Log in here.
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universitiesTom Ellis is a Professor of Synthetic Genome Engineering in the Department of Bioengineering at Imperial College London. He obtained his PhD from the University of Cambridge in 2004, where he researched drugs that bind directly to the promoter elements of cancer genes under the supervision of Michael J. Waring. Following his PhD, he worked at the biotech company Spirogen, establishing a biological screening unit and developing high-throughput assays to characterise drug interactions with oncogene promoters. In 2006, Prof. Ellis returned to academia, spending two years at Boston University in the USA, where he investigated synthetic biology in one of the founding groups of the field under the supervision of Jim Collins. During this time, he devised a synthesis-based library approach to engineering gene regulatory networks, successfully modelling and implementing this method in nonlinear systems relevant to biofuel and beer production. Before joining Imperial College in 2009, he returned to the UK to conduct research in synthetic biology at the Institute of Biotechnology at the University of Cambridge. Prof. Ellis has authored over 60 publications in synthetic biology, contributing to prestigious journals such as Science, Cell, Nature Methods, Nature Biotechnology, PNAS, and Nature Reviews. He has led a UK-funded project to construct a synthetic yeast chromosome for the international synthetic yeast project (Sc2.0) and has been a pioneer in the field of Engineered Living Materials. He co-leads the teaching of Imperial’s synthetic biology undergraduate module and has received multiple awards for his teaching and supervision of iGEM teams. His research focuses on developing foundational tools for design-led synthetic genomics and synthetic biology, particularly in yeast (S. cerevisiae), and includes projects aimed at growing new functional biomaterials, alongside various other synthetic biology projects relevant to industry and medicine.
Tom Ellis''s main research interests include synthetic genomics, engineered living materials, synthetic biology, genome engineering, the function of DNA sequence, and programming biosynthesis of new therapeutics. He leads a research team focused on developing foundational tools for design-led synthetic genomics and synthetic biology, with particular emphasis on projects involving yeast (S. cerevisiae) aimed at growing new functional biomaterials. His group also engages in a variety of synthetic biology projects relevant to industry and medicine. Tom Ellis has authored over 60 publications in synthetic biology, contributing to prestigious journals such as Science, Cell, Nature Methods, Nature Biotechnology, PNAS, and Nature Reviews. He has been a pioneer in the field of Engineered Living Materials and has led significant projects, including the UK-funded initiative to build a synthetic yeast chromosome for the international synthetic yeast project (Sc2.0).